Showing results (1-10 of 147) with videos related to
Sort By:
Pageof 15
Current Opinion in Investigational Drugs (London, England : 2000)|February 7, 2004
Raf pathway inhibitors in oncologyGideon Bollag, Scott Freeman, John F Lyons, et al.Current Topics in Microbiology and Immunology|August 3, 2011
Setting up a kinase discovery and development projectGideon BollagCurrent Opinion in Genetics & Development|November 26, 2009
Scaffold-based design of kinase inhibitors for cancer therapyChao Zhang, Gideon BollagCancer Discovery|April 5, 2017
Anaphase-Promoting Complex Adaptor FZR1/CDH1 Blocks BRAF Signaling Both by Targeting BRAF for Proteolytic Degradation and by Disrupting BRAF DimerizationChao Zhang, Gideon BollagCancer Research|January 16, 2026
Overcoming the Limits of Inhibition: Mutant-Selective BRAF DegradersPan-Yu Chen, Gideon BollagCurrent Opinion in Investigational Drugs (London, England : 2000)|January 17, 2003
Selectively replicating adenoviruses for cancer therapy: an update on clinical developmentLeonard E PostNature Reviews. Cancer|March 27, 2007
Hyperactive Ras in developmental disorders and cancerSuzanne Schubbert, Kevin Shannon, Gideon BollagCurrent Opinion in Genetics & Development|January 9, 2007
Deregulated Ras signaling in developmental disorders: new tricks for an old dogSuzanne Schubbert, Gideon Bollag, Kevin ShannonExpert Opinion on Therapeutic Targets|November 23, 2005
Phosphodiesterase-4 as a potential drug targetKam Y J Zhang, Prabha N Ibrahim, Sam Gillette, et al.Pageof 15